Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
48 hedge funds and large institutions have $52M invested in Histogen Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 6 closing their positions.
200% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 6
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
37% more capital invested
Capital invested by funds: $37.8M → $52M (+$14.2M)
33% more funds holding
Funds holding: 36 → 48 (+12)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Axa
Paris,
France
|
+$3.06M |
| 2 |
GTC
Ghost Tree Capital
New York
|
+$2.3M |
| 3 |
JC
JBF Capital
Aspen,
Colorado
|
+$1.55M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$1.3M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Polar Capital
London,
United Kingdom
|
-$2.85M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$1.5M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$875K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$683K |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$627K |
HSTO Hedge Fund Activity: Q1 2014 in Review
48 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q1 2014, worth a combined $52M — up 37% from $37.8M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new HSTO positions and 6 closed out — a net gain of 12 holders — while 14 added to existing stakes and 9 trimmed.
The largest buyer was Axa, opening a new position worth an estimated $3.06M. The largest seller was Polar Capital, cutting an estimated $2.85M.
- 48 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q1 2014, up from 36 in Q4 2013.
- Funds reported $52M of Histogen Inc. Common Stock stock for Q1 2014, up 37% quarter-over-quarter.
- 18 funds opened new Histogen Inc. Common Stock positions in Q1 2014 and 6 closed out, a net change of +12 holders.
- The largest Histogen Inc. Common Stock buyer in Q1 2014 was Axa, an estimated $3.06M added.
- The largest Histogen Inc. Common Stock seller in Q1 2014 was Polar Capital, an estimated $2.85M sold.
Based on aggregated 13F filings for Q1 2014.